Stock-based Compensation (Tables)

9 Months Ended

Sep. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Changes in Common Stock Options

The following summarizes the changes in common stock options for the nine months ended September 30, 2026:


		Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value (In thousands)
Outstanding as of December 31, 2025			2,172,600			$	1.76				5.1			$	408
Granted			1,160,000			$	1.28
Exercised			(52,125	)		$	0.60
Forfeited			(45,000	)		$	0.70
Outstanding as of September 30, 2026			3,235,475			$	1.62				6.2			$	402

Options exercisable as of September 30, 2026			1,854,225			$	1.73				4.1			$	379

Schedule of Restricted Stock Awards and Stock-based Compensation

The following summarizes the restricted stock awards and related stock-based compensation expense (in thousands, except share count and award fair value):


		Grant Date		Vesting Date		Restricted Stock Granted				Per Share Grant Date Fair Value				Compensation Expense for the nine months ended September 30,								Unrecognized Compensation Expense as of,
		Grant Date		Vesting Date		Restricted Stock Granted				Per Share Grant Date Fair Value				2025				2026				September 30, 2026
Employees		March 7, 2024		March 7, 2025			128,044			$	2.93				67				—				—
Non-executive directors		March 7, 2024		March 7, 2025			75,000			$	2.93				40				—				—
Employees		January 1, 2025		December 31, 2028 [1]			125,000			$	1.85				43				43				130
Employees		March 6, 2025		March 6, 2026			68,051			$	2.11				82				26				—
Non-executive directors		March 6, 2025		March 6, 2026			100,000			$	2.11				120				38				—
Non-executive directors		March 5, 2026		March 5, 2027 [2]			100,000			$	1.30				—				74				56
Total														$	352			$	181			$	186

[1] These restricted stock awards vest 25% annually over four years, until fully vested on December 31, 2028.

[2] These restricted stock awards vest 25% quarterly over one year, until fully vested on March 5, 2027.